IDENTIFICATION AND ISOLATION OF A MEMBRANE-PROTEIN NECESSARY FOR LEUKOTRIENE PRODUCTION

被引:451
作者
MILLER, DK
GILLARD, JW
VICKERS, PJ
SADOWSKI, S
LEVEILLE, C
MANCINI, JA
CHARLESON, P
DIXON, RAF
FORDHUTCHINSON, AW
FORTIN, R
GAUTHIER, JY
RODKEY, J
ROSEN, R
ROUZER, C
SIGAL, IS
STRADER, CD
EVANS, JF
机构
[1] MERCK FROSST CTR THERAPEUT RES,DEPT MED CHEM,POINTE CLAIRE H9R 4P8,QUEBEC,CANADA
[2] MERCK FROSST CTR THERAPEUT RES,DEPT PHARMACOL,POINTE CLAIRE H9R 4P8,QUEBEC,CANADA
[3] MERCK SHARP & DOHME LTD,DEPT MOLEC BIOL,W POINT,PA 19486
关键词
D O I
10.1038/343278a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SEVERAL inflammatory diseases, including asthma, arthritis and psoriasis are associated with the production of leukotrienes by neutrophils, mast cells and macrophages1-3. The initial enzymatic step in the formation of leukotrienes is the oxidation of arachidonic acid by 5-lipoxygenase (5-LO) to leukotriene A4 (refs 4-6). Osteosarcoma cells transfected with 5-LO express active enzyme in broken cell preparations, but no leukotriene metabolites are produced by these cells when stimulated with the calcium ionophore A23187, indicating that an additional component is necessary for cellular 5-LO activity7. A new class of indole leukotriene inhibitor has been described that inhibits the formation of cellular leukotrienes but has no direct inhibitory effect on soluble 5-LO activity8. We have now used these potent agents to identify and isolate a novel membrane protein of relative molecular mass 18,000 which is necessary for cellular leukotriene synthesis. © 1990 Nature Publishing Group.
引用
收藏
页码:278 / 281
页数:4
相关论文
共 16 条
  • [1] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [3] GAN ZR, 1989, GENE, V79, P159
  • [4] L-663,536 (MK-886) (3-[1-(4-CHLOROBENZYL)-3-T-BUTYL-THIO-5-ISOPROPYLINDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID), A NOVEL, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR
    GILLARD, J
    FORDHUTCHINSON, AW
    CHAN, C
    CHARLESON, S
    DENIS, D
    FOSTER, A
    FORTIN, R
    LEGER, S
    MCFARLANE, CS
    MORTON, H
    PIECHUTA, H
    RIENDEAU, D
    ROUZER, CA
    ROKACH, J
    YOUNG, R
    MACINTYRE, DE
    PETERSON, L
    BACH, T
    EIERMANN, G
    HOPPLE, S
    HUMES, J
    HUPE, L
    LUELL, S
    METZGER, J
    MEURER, R
    MILLER, DK
    OPAS, E
    PACHOLOK, S
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (05) : 456 - 464
  • [5] Guindon Y, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P554
  • [6] INHIBITION BY PROSTAGLANDINS OF LEUKOTRIENE-B4 RELEASE FROM ACTIVATED NEUTROPHILS
    HAM, EA
    SODERMAN, DD
    ZANETTI, ME
    DOUGHERTY, HW
    MCCAULEY, E
    KUEHL, FA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14): : 4349 - 4353
  • [7] INTERACTIONS BETWEEN PROSTAGLANDINS AND LEUKOTRIENES - COMMENTARY
    KUEHL, FA
    DOUGHERTY, HW
    HAM, EA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (01) : 1 - 5
  • [8] ROKACH J, 1989, LEUKOTRIENES LIPOXYG
  • [9] SINGLE PROTEIN FROM HUMAN-LEUKOCYTES POSSESSES 5-LIPOXYGENASE AND LEUKOTRIENE-A4 SYNTHASE ACTIVITIES
    ROUZER, CA
    MATSUMOTO, T
    SAMUELSSON, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (04) : 857 - 861
  • [10] ROUZER CA, 1988, J BIOL CHEM, V263, P10980